David Hovland
Algemeen Adviseur bij ELEDON PHARMACEUTICALS, INC.
Actieve functies van David Hovland
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Algemeen Adviseur | 19-04-2021 | - |
Loopbaan van David Hovland
Eerdere bekende functies van David Hovland
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| UROVANT SCIENCES LTD. | Algemeen Adviseur | 01-04-2018 | 01-04-2021 |
| ALLERGAN PLC | Algemeen Adviseur | 01-01-2015 | 01-01-2018 |
| Corporate Officer/Principal | 01-01-2010 | 01-01-2015 | |
| AMGEN INC. | Algemeen Adviseur | 01-01-2006 | 01-01-2010 |
| ALLERGAN PLC | Corporate Officer/Principal | 01-01-1999 | 01-01-2002 |
Opleiding van David Hovland
| University of California, Los Angeles | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 2 |
| Ierland | 2 |
Operationeel
| General Counsel | 4 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Beurs
- Insiders
- David Hovland
- Ervaring